Population screening for glucose-6-phosphate dehydrogenase deficiencies in Isabel Province, Solomon Islands, using a modified enzyme assay on filter paper dried bloodspots.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMC 2924349)

Published in Malar J on August 05, 2010

Authors

Melissa Kuwahata1, Rushika Wijesinghe, Mei-Fong Ho, Anita Pelecanos, Albino Bobogare, Losi Landry, Hugo Bugora, Andrew Vallely, James McCarthy

Author Affiliations

1: Queensland Institute of Medical Research, Herston, QLD 4006, Australia.

Articles citing this

Operational strategies to achieve and maintain malaria elimination. Lancet (2010) 6.48

Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J (2013) 1.89

Focused Screening and Treatment (FSAT): a PCR-based strategy to detect malaria parasite carriers and contain drug resistant P. falciparum, Pailin, Cambodia. PLoS One (2012) 1.66

G6PD testing in support of treatment and elimination of malaria: recommendations for evaluation of G6PD tests. Malar J (2013) 1.40

Operational research to inform a sub-national surveillance intervention for malaria elimination in Solomon Islands. Malar J (2012) 1.25

Tools for mass screening of G6PD deficiency: validation of the WST8/1-methoxy-PMS enzymatic assay in Uganda. Malar J (2013) 1.09

Suitability of capillary blood for quantitative assessment of G6PD activity and performances of G6PD point-of-care tests. Am J Trop Med Hyg (2015) 1.05

Performance of the CareStart glucose-6-phosphate dehydrogenase (G6PD) rapid diagnostic test in Gressier, Haiti. Am J Trop Med Hyg (2014) 1.04

Comparison of quantitative and qualitative tests for glucose-6-phosphate dehydrogenase deficiency. Am J Trop Med Hyg (2014) 0.98

Comparison of Three Screening Test Kits for G6PD Enzyme Deficiency: Implications for Its Use in the Radical Cure of Vivax Malaria in Remote and Resource-Poor Areas in the Philippines. PLoS One (2016) 0.93

Modeling Plasmodium vivax: relapses, treatment, seasonality, and G6PD deficiency. J Theor Biol (2012) 0.91

A Comparison of Three Quantitative Methods to Estimate G6PD Activity in the Chittagong Hill Tracts, Bangladesh. PLoS One (2017) 0.77

Prevalence of G6PD deficiency in selected populations from two previously high malaria endemic areas of Sri Lanka. PLoS One (2017) 0.75

Diagnosis and Treatment of Plasmodium vivax Malaria. Am J Trop Med Hyg (2016) 0.75

Articles cited by this

Glucose-6-phosphate dehydrogenase deficiency. Lancet (2008) 8.26

Use of filter paper for the collection and analysis of human whole blood specimens. J Nutr (2001) 3.85

Malaria eradication on islands. Lancet (2000) 3.51

Glucose-6-phosphate dehydrogenase deficiency. WHO Working Group. Bull World Health Organ (1989) 3.48

The role of anti-malarial drugs in eliminating malaria. Malar J (2008) 3.45

The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis (2009) 3.44

Dried blood spots as a source of anti-malarial antibodies for epidemiological studies. Malar J (2008) 3.02

X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. PLoS Med (2007) 2.94

Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg (2006) 2.86

Glucose-6-phosphate dehydrogenase deficiency: a historical perspective. Blood (2008) 2.33

Can primaquine therapy for vivax malaria be improved? Trends Parasitol (2003) 2.31

Methaemoglobin reduction test: a new, simple, in vitro test for identifying primaquine-sensitivity. Bull World Health Organ (1960) 2.28

The epidemiology of malaria in Papua New Guinea. Trends Parasitol (2003) 2.03

G6PD deficiency: the genotype-phenotype association. Blood Rev (2007) 1.86

International Committee for Standardization in Haematology: recommended screening test for glucose-6-phosphate dehydrogenase (G-6-PD) deficiency. Br J Haematol (1979) 1.71

Glucose-6-phosphate dehydrogenase deficiency. Baillieres Best Pract Res Clin Haematol (2000) 1.60

A community-directed strategy for sustainable malaria elimination on islands: short-term MDA integrated with ITNs and robust surveillance. Acta Trop (2010) 1.58

Glucose-6-phosphate dehydrogenase deficiency and malaria: cytochemical detection of heterozygous G6PD deficiency in women. J Histochem Cytochem (2009) 1.36

An improved, simple screening method for detection of glucose-6-phosphate dehydrogenase deficiency. Trop Med Int Health (2003) 1.33

Field trials of a rapid test for G6PD deficiency in combination with a rapid diagnosis of malaria. Trop Med Int Health (1999) 1.30

Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database Syst Rev (2007) 1.29

Malaria epidemiology, glucose 6-phosphate dehydrogenase deficiency and human settlement in the Vanuatu Archipelago. Acta Trop (1998) 1.19

High risk of severe anaemia after chlorproguanil-dapsone+artesunate antimalarial treatment in patients with G6PD (A-) deficiency. PLoS One (2008) 1.18

Present status of understanding on the G6PD deficiency and natural selection. J Postgrad Med (2007) 1.03

A sensitive cytochemical staining method for glucose-6-phosphate dehydrogenase activity in individual erythrocytes. I. Optimalization of the staining procedure. Histochemistry (1982) 1.02

Multiple glucose 6-phosphate dehydrogenase-deficient variants correlate with malaria endemicity in the Vanuatu archipelago (southwestern Pacific). Am J Hum Genet (1995) 0.99

Pharmacokinetics of primaquine in G6PD deficient and G6PD normal patients with vivax malaria. Trans R Soc Trop Med Hyg (1994) 0.95

Rapid epidemiologic assessment of glucose-6-phosphate dehydrogenase deficiency in malaria-endemic areas in Southeast Asia using a novel diagnostic kit. Trop Med Int Health (2004) 0.93

Genetic benefits of consanguinity through selection of genotypes protective against malaria. Hum Biol (2007) 0.89

Screening for glucose-6-phosphate dehydrogenase deficiency using a modified formazan method: a pilot study on Filipino male newborns. Pediatr Int (2003) 0.87

A simple method for collecting measured whole blood with quantitative recovery of antibody activities for serological surveys. J Immunol Methods (2007) 0.86

Distribution pattern of an inherited trait, red cell enzyme deficiency, in New Guinea and New Britain. Am J Phys Anthropol (1962) 0.84

Glucose-6-phosphate dehydrogenase deficiency in Papua New Guinea. The description of 13 new variants. Hum Genet (1982) 0.83

A new simple screening method for glucose 6-phosphate dehydrogenase deficiency. Nihon Ketsueki Gakkai Zasshi (1984) 0.83

Mass screening for glucose-6-phosphate dehydrogenase deficiency: improved fluorescent spot test. Clin Chim Acta (1985) 0.83

Distribution of beta-thalassemia trait and erythrocyte glucose-6-phosphate dehydrogenase deficiency in the Markham River Valley of New Guinea. Am J Phys Anthropol (1967) 0.81

Reactivity of blood samples spotted onto filter papers in the WST-8 method for screening of G6PD deficiency. Acta Med Okayama (2006) 0.81

Simplified method for G6PD screening using blood collected on filter paper. Am J Clin Pathol (1974) 0.78

Articles by these authors

Genetic diversity of Plasmodium falciparum histidine-rich protein 2 (PfHRP2) and its effect on the performance of PfHRP2-based rapid diagnostic tests. J Infect Dis (2005) 4.58

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet (2010) 3.90

A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu Province, Solomon Islands: challenges for malaria diagnostics in an elimination setting. Malar J (2010) 3.81

A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: implications for malaria rapid diagnostic tests. PLoS One (2010) 3.50

Using serological measures to monitor changes in malaria transmission in Vanuatu. Malar J (2010) 2.47

Effect of sequence variation in Plasmodium falciparum histidine- rich protein 2 on binding of specific monoclonal antibodies: Implications for rapid diagnostic tests for malaria. J Clin Microbiol (2006) 2.45

A qualitative study on the acceptability and preference of three types of long-lasting insecticide-treated bed nets in Solomon Islands: implications for malaria elimination. Malar J (2009) 2.33

Community participation for malaria elimination in Tafea Province, Vanuatu: Part I. Maintaining motivation for prevention practices in the context of disappearing disease. Malar J (2010) 2.04

Review of key knowledge gaps in glucose-6-phosphate dehydrogenase deficiency detection with regard to the safe clinical deployment of 8-aminoquinoline treatment regimens: a workshop report. Malar J (2013) 1.89

The architecture and effect of participation: a systematic review of community participation for communicable disease control and elimination. Implications for malaria elimination. Malar J (2011) 1.88

Global sequence variation in the histidine-rich proteins 2 and 3 of Plasmodium falciparum: implications for the performance of malaria rapid diagnostic tests. Malar J (2010) 1.77

Total ischemic time: the correct focus of attention for optimal ST-segment elevation myocardial infarction care. JACC Cardiovasc Interv (2011) 1.75

Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions? J Cell Sci (2008) 1.73

Malaria elimination: moving forward with spatial decision support systems. Trends Parasitol (2012) 1.54

Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements) Study. Am J Kidney Dis (2010) 1.53

Assessing the genetic diversity of the aldolase genes of Plasmodium falciparum and Plasmodium vivax and its potential effect on performance of aldolase-detecting rapid diagnostic tests. J Clin Microbiol (2006) 1.45

Baseline spatial distribution of malaria prior to an elimination programme in Vanuatu. Malar J (2010) 1.37

Transcription and expression of Plasmodium falciparum histidine-rich proteins in different stages and strains: implications for rapid diagnostic tests. PLoS One (2011) 1.35

Scope and design of the Following Rehabilitation, Economics and Everyday-Dialysis Outcome Measurements (FREEDOM) Study. Am J Kidney Dis (2008) 1.31

A model for community representation and participation in HIV prevention trials among women who engage in transactional sex in Africa. AIDS Care (2008) 1.30

Changes in vector species composition and current vector biology and behaviour will favour malaria elimination in Santa Isabel Province, Solomon Islands. Malar J (2011) 1.29

Operational research to inform a sub-national surveillance intervention for malaria elimination in Solomon Islands. Malar J (2012) 1.25

Malaria elimination in Isabel Province, Solomon Islands: establishing a surveillance-response system to prevent introduction and reintroduction of malaria. Malar J (2011) 1.24

A typology of penile cutting in Papua New Guinea: results of a modified Delphi study among sexual health specialists. AIDS Care (2011) 1.16

"Now we are in a different time; various bad diseases have come." Understanding men's acceptability of male circumcision for HIV prevention in a moderate prevalence setting. BMC Public Health (2012) 1.16

Functional reinnervation of the canine bladder after spinal root transection and immediate somatic nerve transfer. J Neurotrauma (2008) 1.16

A cluster randomized controlled cross-over bed net acceptability and preference trial in Solomon Islands: community participation in shaping policy for malaria elimination. Malar J (2009) 1.16

Community participation for malaria elimination in Tafea Province, Vanuatu: part II. Social and cultural aspects of treatment-seeking behaviour. Malar J (2011) 1.15

The effect of insecticide synergists on the response of scabies mites to pyrethroid acaricides. PLoS Negl Trop Dis (2009) 1.14

Toward the global control of human scabies: introducing the International Alliance for the Control of Scabies. PLoS Negl Trop Dis (2013) 1.14

Plasmodium falciparum parasites lacking histidine-rich protein 2 and 3: a review and recommendations for accurate reporting. Malar J (2014) 1.14

Identification of optimal epitopes for Plasmodium falciparum rapid diagnostic tests that target histidine-rich proteins 2 and 3. J Clin Microbiol (2012) 1.13

Mapping malaria risk in Bangladesh using Bayesian geostatistical models. Am J Trop Med Hyg (2010) 1.13

Intravaginal and menstrual practices among women working in food and recreational facilities in Mwanza, Tanzania: implications for microbicide trials. AIDS Behav (2010) 1.13

Acaricidal activity of eugenol based compounds against scabies mites. PLoS One (2010) 1.11

Encysted seizures: status epilepticus in a recently resettled refugee child. Med J Aust (2010) 1.11

Sexual risk behaviour for women working in recreational venues in Mwanza, Tanzania: considerations for the acceptability and use of vaginal microbicide gels. Cult Health Sex (2009) 1.10

Suitability of simple human immunodeficiency virus rapid tests in clinical trials in community-based clinic settings. J Clin Microbiol (2009) 1.10

Scabies: molecular perspectives and therapeutic implications in the face of emerging drug resistance. Future Microbiol (2008) 1.10

A high-resolution geospatial surveillance-response system for malaria elimination in Solomon Islands and Vanuatu. Malar J (2013) 1.10

Modern geographical reconnaissance of target populations in malaria elimination zones. Malar J (2010) 1.09

A tractable experimental model for study of human and animal scabies. PLoS Negl Trop Dis (2010) 1.09

Validity of coital diaries in a feasibility study for the Microbicides Development Programme trial among women at high risk of HIV/AIDS in Mwanza, Tanzania. Sex Transm Infect (2007) 1.08

Exploring provider and community responses to the new malaria diagnostic and treatment regime in Solomon Islands. Malar J (2011) 1.07

Low doses of killed parasite in CpG elicit vigorous CD4+ T cell responses against blood-stage malaria in mice. J Clin Invest (2010) 1.05

Skin disorders, including pyoderma, scabies, and tinea infections. Pediatr Clin North Am (2009) 1.03

Differential regulation of grain sucrose accumulation and metabolism in Coffea arabica (Arabica) and Coffea canephora (Robusta) revealed through gene expression and enzyme activity analysis. New Phytol (2008) 1.02

Why women object to male circumcision to prevent HIV in a moderate-prevalence setting. Qual Health Res (2012) 1.02

Population genetics of Plasmodium falciparum and Plasmodium vivax and asymptomatic malaria in Temotu Province, Solomon Islands. Malar J (2013) 1.01

Strongyloidiasis: a review of the evidence for Australian practitioners. Aust J Rural Health (2005) 0.99

The larval specific lymphatic filarial ALT-2: induction of protection using protein or DNA vaccination. Microbiol Immunol (2004) 0.99

Membrane ganglioside enrichment lowers the threshold for vascular endothelial cell angiogenic signaling. Cancer Res (2006) 0.99

Evidences of protection against blood-stage infection of Plasmodium falciparum by the novel protein vaccine SE36. Parasitol Int (2010) 0.98

Oleosin gene family of Coffea canephora: quantitative expression analysis of five oleosin genes in developing and germinating coffee grain. J Plant Physiol (2006) 0.97

Gigantic unruptured sinus of Valsalva aneurysm presenting as an incidental murmur. BMJ Case Rep (2012) 0.97

A time-frequency based electromyographic analysis technique for use in cerebral palsy. Gait Posture (2006) 0.96

Comparison of sexual behavior data collected using a coital diary and a clinic-based interview during a microbicide pilot study in Mwanza, Tanzania. Sex Transm Dis (2010) 0.96

Isolation and characterization of cDNA encoding three dehydrins expressed during Coffea canephora (Robusta) grain development. Ann Bot (2006) 0.94

More than just a cut: a qualitative study of penile practices and their relationship to masculinity, sexuality and contagion and their implications for HIV prevention in Papua New Guinea. BMC Int Health Hum Rights (2012) 0.93

An improved method for undertaking limiting dilution assays for in vitro cloning of Plasmodium falciparum parasites. Malar J (2011) 0.93

Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis (2008) 0.93

Molecular characterisation of a pH-gated chloride channel from Sarcoptes scabiei. Invert Neurosci (2007) 0.93

Influence of environmental factors on the abundance of Anopheles farauti larvae in large brackish water streams in Northern Guadalcanal, Solomon Islands. Malar J (2011) 0.93

Thromboelastography in patients with acute ischemic stroke. Int J Stroke (2012) 0.91

Effect of Borrelia burgdorferi OspC at the site of inoculation in mouse skin. Infect Immun (2010) 0.89

Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis? Am J Trop Med Hyg (2005) 0.89

Immunization with a tetraepitopic lipid core peptide vaccine construct induces broadly protective immune responses against group A streptococcus. J Infect Dis (2006) 0.89

An investigation of carotenoid biosynthesis in Coffea canephora and Coffea arabica. J Plant Physiol (2007) 0.88

Gait initiation in children with cerebral palsy. Gait Posture (2007) 0.88

Design and synthesis of tricyclic corticotropin-releasing factor-1 antagonists. J Med Chem (2005) 0.87

Circulating antibodies against Plasmodium falciparum histidine-rich proteins 2 interfere with antigen detection by rapid diagnostic tests. Malar J (2014) 0.87

PCR-based assay to survey for knockdown resistance to pyrethroid acaricides in human scabies mites (Sarcoptes scabiei var hominis). Am J Trop Med Hyg (2006) 0.87

Early treatment of scoliosis with growing rods in children with severe spinal muscular atrophy: a preliminary report. J Pediatr Orthop (2011) 0.86

Exploring women's perspectives of access to care during pregnancy and childbirth: a qualitative study from rural Papua New Guinea. Midwifery (2013) 0.86

Evaluation of noninvasive hemoglobin measurements in trauma patients. Am J Surg (2013) 0.85

Botulinum toxin type A injection in alleviating postoperative pain and improving quality of life in lower extremity limb lengthening and deformity correction: a pilot study. J Pediatr Orthop (2009) 0.84

Sociocultural and individual determinants for motivation of sexual and reproductive health workers in Papua New Guinea and their implications for male circumcision as an HIV prevention strategy. Hum Resour Health (2013) 0.84

Laboratory-acquired dengue virus infection--a case report. PLoS Negl Trop Dis (2011) 0.83

Contained and high-level production of recombinant protein in plant chloroplasts using a temporary immersion bioreactor. Plant Biotechnol J (2010) 0.83

Updating memory after mild traumatic brain injury and orthopedic injuries. J Neurotrauma (2013) 0.83

Bilateral congenital subtalar dislocation: a case report. Clin Orthop Relat Res (2002) 0.82

Evidence behind the WHO guidelines: Hospital care for children: What is the most appropriate treatment for giardiasis? J Trop Pediatr (2008) 0.82

Expression of the affinity tags, glutathione-S-transferase and maltose-binding protein, in tobacco chloroplasts. Planta (2012) 0.82

Characterization, high-resolution mapping and differential expression of three homologous PAL genes in Coffea canephora Pierre (Rubiaceae). Planta (2012) 0.82

Achieving control of cervical cancer in Papua New Guinea: what are the research and program priorities? P N G Med J (2014) 0.81

Evaluation of force-sensing resistors for gait event detection to trigger electrical stimulation to improve walking in the child with cerebral palsy. IEEE Trans Neural Syst Rehabil Eng (2002) 0.81

Analysis of renal bone disease treatment in dialysis patients. Am J Kidney Dis (2002) 0.80

An outbreak of mediastinitis among heart transplant recipients apparently related to a change in the united network for organ sharing guidelines. Infect Control Hosp Epidemiol (2002) 0.80